Biomea Fusion, Inc.
- BMEA
- NASDAQ
- Biotechnology
- Covalent Small Molecule Drugs
- Oncology & Metabolic Diseases
$0.87
Today +3.89%Quote Oct 16, 2026, 08:00 PM UTC
−51.46%over the last month
Max drawdown −54.4%From 1-month high −52.5%3 months −33.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$62.8M
Quote Oct 16
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$20.20
+2224.8% from here
Floor
—
Data unavailable
Where the price sits
14 analysts
Analyst range, low to high
$10.00$40.00
- Price $0.87
- Resistance $0.87
- Consensus $20.20
Analysts' average target sits about 2225% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BMEAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
37
Founded
2017